|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500097455 |
|
最近更新日期: Date of Last Refreshed on: |
2025-02-19 15:05:35 |
|
注册时间: Date of Registration: |
2025-02-19 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
基于积极老龄化体验的老年癌症长期生存者抑郁风险预测模型及复杂干预方案的构建 |
|
Public title: |
Development of a Risk Prediction Model of Depression and the Complex Intervention Program for Elderly Long-Term Cancer Survivors Based on the Experience of Positive Ageing |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
基于积极老龄化体验的老年癌症长期生存者抑郁风险预测模型及复杂干预方案的构建 |
|
Scientific title: |
Development of a Risk Prediction Model of Depression and the Complex Intervention Program for Elderly Long-Term Cancer Survivors Based on the Experience of Positive Ageing |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
刘谆谆 |
研究负责人: |
陆云南/刘谆谆 |
|
Applicant: |
Zhunzhun Liu |
Study leader: |
Yunnan Lu/Zhunzhun Liu |
|
申请注册联系人电话: Applicant telephone: |
+86 152 5159 0580 |
研究负责人电话:
Study leader's |
+86 152 5159 0580 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
liuzz@wxu.edu.cn |
研究负责人电子邮件: Study leader's E-mail: |
liuzz@wxu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
江苏省无锡市钱荣路68号 |
研究负责人通讯地址: |
江苏省无锡市锡山区安镇街道大成路1128号/江苏省无锡市钱荣路68号 |
|
Applicant address: |
No. 68 Qianrong Street, Wuxi, Jiangsu Province, China |
Study leader's address: |
No. 1128, Dacheng Road, Anting Sub-district, Wuxi City, Jiangsu Province, China /No. 68 Qianrong Street, Wuxi, Jiangsu Province, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
无锡太湖学院 |
||
|
Applicant's institution: |
Wuxi Taihu University |
||
|
研究负责人所在单位: |
无锡市锡山人民医院/无锡太湖学院 |
||
|
Affiliation of the Leader: |
Xishan People's Hospital of Wuxi City/Wuxi Taihu University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
xs2024ky077 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
无锡市锡山人民医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics committee of Xishan People’s Hospital of Wuxi City |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-12-25 00:00:00 | ||
|
伦理委员会联系人: |
拜红霞 |
||
|
Contact Name of the ethic committee: |
Hongxia Bai |
||
|
伦理委员会联系地址: |
江苏省无锡市安镇街道大成路1128号 |
||
|
Contact Address of the ethic committee: |
No. 1128, Dacheng Road, Anting Sub-district, Wuxi City, Jiangsu Province, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 133 9514 2373 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
无锡市锡山人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Xishan People’s Hospital of Wuxi City |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
江苏省无锡市安镇街道大成路1128号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 1128, Dacheng Road, Anting Sub-district, Wuxi City, Jiangsu Province, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
国家自然科学基金资助项目(项目批准号:82404052) |
||||||||||||||||||||||
|
Source(s) of funding: |
Project supported by the National Natural Science Foundation of China |
||||||||||||||||||||||
|
研究疾病: |
癌症 |
||||||||||||||||||||||
|
Target disease: |
Cancer |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
开发基于积极老龄化体验的老年癌症长期生存者抑郁预测模型,构建并验证老年癌症长期生存者抑郁干预方案。 |
||||||||||||||||||||||
|
Objectives of Study: |
To develop a depression prediction model for elderly cancer long-term survivors based on positive aging experiences, and construct and validate an intervention program for depression in elderly cancer long-term survivors. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
年龄≥60 岁;癌诊诊断后 5 年以上。 |
||||||||||||||||||||||
|
Inclusion criteria |
Aged >=60 years; more than 5 years after cancer diagnosis. |
||||||||||||||||||||||
|
排除标准: |
老年人快速评估量表中的快速认知筛查工具得分<8分,中重度认知障碍;近半年内或目前正在进行其他心理治疗。 |
||||||||||||||||||||||
|
Exclusion criteria: |
A score of <8 points in the Geriatric Rapid Assessment Measure or diagnosed with moderate to severe cognitive impairment; participants have undergone other psychological treatments in the past six months or are currently undergoing other psychological treatments. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-01-01 00:00:00至 To 2027-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-03-01 00:00:00 至 To 2027-08-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
干预研究的样本均来自同一家医院,为保证两组样本均衡,研究者采用区组随机法将研究对象分为干预组(A)和对照组(B):将88名研究对象按纳入时间先后顺序分22组,每组4名(6种排列方式,即6个区组号),随机抽取22次区组号。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
To ensure the balance of the two groups, the researchers used cluster randomization to divide the research subjects into the intervention group (A) and the control group (B): The 88 research subjects were divided into 22 groups according to the order of enrollment, with 4 in each group (6 different arrangement methods, i.e., 6 cluster numbers), and 22 cluster numbers were randomly drawn. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
单盲:结果测量者施盲。 |
|
Blinding: |
Single-blind: The outcome investigators are blinded. |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
研究结束后,公开发表学术论文 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Once the study is concluded, academic papers will be published. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |